Compared to the mutation frequencies reported in the TCGA CRC dataset, the mutation frequency in TP53 (72%) was higher in our cohort, the frequencies of PIK3CA (25%) and FBXW7 (21%) mutations were relatively equal, and the frequency of mutation in KRAS (37%) was relatively lower. This evidence concerns the gene KRAS and colorectal carcinoma.